MedPath

Stein Mark

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:3
Completed:0

Trial Phases

2 Phases

Phase 1:2
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
2 (50.0%)

Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Phase 1
Active, not recruiting
Conditions
Recurrent Prostate Cancer
Interventions
First Posted Date
2021-10-14
Last Posted Date
2025-04-25
Lead Sponsor
Mark Stein
Target Recruit Count
8
Registration Number
NCT05077098
Locations
🇺🇸

Columbia University Irving Medical Center, New York, New York, United States

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

Phase 2
Recruiting
Conditions
Kidney Cancer
Renal Cell Carcinoma
Interventions
Procedure: Cytoreductive nephrectomy
First Posted Date
2020-03-26
Last Posted Date
2025-04-25
Lead Sponsor
Mark Stein
Target Recruit Count
48
Registration Number
NCT04322955
Locations
🇺🇸

The Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

🇺🇸

Columbia University Irving Medical Center, New York, New York, United States

🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

and more 1 locations

REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer

Phase 2
Active, not recruiting
Conditions
Prostate Cancer Metastatic
Interventions
First Posted Date
2019-05-15
Last Posted Date
2025-04-25
Lead Sponsor
Mark Stein
Target Recruit Count
26
Registration Number
NCT03951831
Locations
🇺🇸

Columbia University Irving Medical Center, New York, New York, United States

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Phase 1
Active, not recruiting
Conditions
Prostate Cancer
Adenocarcinoma of the Prostate
Interventions
First Posted Date
2018-09-28
Last Posted Date
2025-04-29
Lead Sponsor
Mark Stein
Target Recruit Count
59
Registration Number
NCT03689699
Locations
🇺🇸

Winship Cancer Institute, Emory University, Atlanta, Georgia, United States

🇺🇸

Weill Cornell Medical Center, New York, New York, United States

🇺🇸

Columbia University Irving Medical Center, New York, New York, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.